Screening Out Retinopathy: Pathways to Improving Diagnosis and Management in Patients with Diabetes
Post-Test/Evaluation

Questions marked with a * are required
37%
Contact Information
Credentials/Degree (MD, DO, etc.)
Date of  Participation
Which of the following statements about diabetic retinopathy (DR) and rates of annual eye screening among racial/ethnic minorities are correct?
Maria is a 52-year-old Hispanic female who has just been diagnosed type 2 diabetes mellitus (T2DM). What eye care recommendation and counseling do you provide regarding evaluation for retinopathy?
John, a 60-year-old Black man with moderately controlled T2DM for 10 years, is diagnosed with DR through his local TeleEye Health Community Outreach retinopathy screening program. He was referred to a retina specialist. Further exam revealed proliferative diabetic retinopathy (PDR) with diabetic macular edema (DME) bilaterally; however, no evidence of hemorrhage and his best-corrected visual acuity (BCVA) is 20/50. John denies needing prescription glasses in the past, but currently uses over-the-counter reading glasses to see small print on his phone. John is recommended treatment of intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections with aflibercept. All of the following would be appropriate measures as part of an individualized, team-based approach EXCEPT?
What is your job role?
What is your type of practice?
How many years have you been in practice?
Please estimate the number of patients with diabetic retinopathy (DR) and/or diabetic macular edema (DME) that you provide for weekly:
Powered by QuestionPro